Insecticides and fungicides lead the market

Due to the adverse effects of weather factors, the end market preparations digested slowly, the domestic market replenishes inventory slowed down, and the impact of the overseas epidemic situation continues, and foreign demand has failed to provide sufficient support to the market, stacking up the domestic operating rate steadily, The new round of projects under construction reached a record high, and the market supply and demand pattern reversed. Insecticides and fungicides led the market, the panic atmosphere was further aggravated, and the original drug market accelerated to decline...

Herbicide market

This month, the price of glyphosate's original medicine remained stable. Due to the impact of drought, the price of yellow phosphorus was relatively high, but it was loose at the end of the month. The delivery of orders by various factories was mainly focused, and the market transaction price was about 21,000 CNY/ton; glufosinate The current supply of the original drug is still tight. The quotation is at a high of 140,000 CNY/ton. The supply is tight, and the manufacturers are willing to increase the price. Compared with the strength of the glufosinate original drug, the decline of the parent drug of diquat is more obvious. The peak season has arrived, but overseas orders are on the sidelines, with market quotes of 33,000 CNY/ton.

The domestic medicine of pendimethalin has come to an end temporarily. Demand has slowed down. At present, export is the mainstay, and the market is reported at 46,000 CNY/ton. The export of fomesafen is weak, domestic stocking is cautious, and the main stock is digested. The market quotation is about 95,000 CNY/ton; the manufacturer of Fluoride is affected by environmental protection and the operating rate is not enough, mainly for export. The market quotation is 46,000 CNY/ton.

The stock of ethoxyfop is relatively low, and it is also in the vacuum period of the drug season. The subsequent demand has not yet appeared, and the market transaction price is about 173,000 CNY/ton; the current market performance of mesotrione is stable, but with the With the increase in upstream supply, market competition is likely to intensify. The current market price is 205,000 CNY/ton.

The upstream raw material price of mefentrazone rose, the market quotation was 105,000 CNY/ton, the medicament solution of memazonin was 37,000 CNY/ton, and the supply was eased compared with the previous period; Intensified competition may be a preliminary sample of later market competition. The market quotation is less than 155,000 CNY/ton; the supply of raw materials for the raw materials of cyproteron has been eased, and the price has dropped. The market quotation is 270,000 CNY/ton.

The operating rate of clethodim was recovered, and the market price dropped to 138,000 CNY/ton. All manufacturers cautiously quoted for orders, and the spot price was slightly tight. The manufacturers of clomazone pine had weak willingness to take orders, the prices of upstream raw materials rose, and the domestic market was low. The source price was reported to 88,000 CNY/ton; the competition of the fipronil market was intensified, the price dropped to less than 580,000 CNY/ton, and the market was in a wait-and-see state; the market price of thidiazuron original drug market was 320,000 CNY/ton, and the demand was weak ; The demand for sulfasulfuron-methyl original drugs has gradually increased, with a market price of 750,000 CNY/ton.

The terminal demand for high-efficiency flupirmethoprim technical drugs is general, and the market is in stock, mainly for export, and the market quotation is 195,000 CNY/ton; the operating rate of refined quizalofop original drugs is increased, and the downstream demand is weak, and the market quotation is 235,000 yuan/ Tons, nicosulfuron original medicines are still tightly supplied, and the inventory is low, but the drug season has passed, and the market transaction price has dropped to less than 320,000 CNY/ton; the stock of original medicines of clofloxacin isooctyl is low and the operating rate is low Low, the market quotation remained high at 230,000 CNY/ton.

The capacity of the amide herbicide market is limited and the supply is tight, but it is approaching the end of the drug application and the demand is gradually weakening.

This month, the price of alachlor was reported to 33,000 CNY/ton; the current delivery price of acetochlor in barrels was 21,000 CNY/ton, the supply was tight, and the price remained high; the price of butachlor was maintained at RMB 23,000/ton; Propalachlor reported 24,000 CNY/ton, Prometholax original drug 24,000 CNY/ton, Phenylchloride 65,000 CNY/ton, less stock .

The inventory of 2,4-D original medicines decreased, and manufacturers' orders increased. The monthly price stabilized at 155,000 CNY/ton; few oxadiazone original medicines opened factories, and the export order gap was large. The quoted price was 320,000 CNY/ton. At a high level, the supply is still very tight; Atrazine original drug manufacturers have a large inventory, and the quotation is 17,500 CNY/ton.

Insecticide market

The market for abamectin fine powder is stable, with a quotation of 680,000 CNY/ton; the avermectin benzoate original drug remains stable, and export orders are gradually increasing, but the overall downward market environment has lowered the market price to 980,000 CNY/tonne.

Due to sluggish exports and high stocks, prices of nicotine-based crude drugs have fallen sharply. The imidacloprid market is still in stock, with a quotation of 100,000 CNY/ton; acetamiprid is still declining, reported at 110,000 CNY/ton; the price of acetamiprid drops to 168,000 CNY/ton; thiamethoxam The operating rate of pharmaceutical factories recovered, and the market price was reported to 92,000 CNY/ton; the prices of clothianidin manufacturers were adjusted back to 135,000 CNY/ton, mainly for export; the market focus of furosemide was increased, and upstream intermediates The problem caused the production capacity of the original medicine to be limited, and the market price fell to 290,000 CNY/ton.

Although the upstream ether aldehydes of pyrethroids are still affected by the India epidemic and imports are difficult, the general market demand has led to a drop in the market of pyrethroids: the demand for high-efficiency cyhalothrin slows down, and the current market price is 195,000 yuan /Tonne; Bifenthrin original drug operating rate increased, the market price of 210,000 CNY/ton; cypermethrin original drug price returned to 87,000 CNY/ton level; high-efficiency cypermethrin parent drug also dropped to 50,000 CNY/ton.

The supply of pymetrozine is still not relieved, and the market price is still above 230,000 CNY/ton this month. It is expected that the supply will continue to be tight; the explosive growth of the final market of chlorfenapyr is currently in the control of aphids. The market price of special-effect medicines was reported at 1.1 million CNY/ton, the price-performance ratio was prominent, the market documents increased, and the transaction volume increased.

Both the bifenazate and methionyl hydrazide are facing the problem of increased production concentration. Affected by the epidemic situation, the operating rate is low and the supply is tight. The prices of this month were reported to 550,000 CNY/ton and 450,000 CNY/ton. The market of chlorfenapyr is facing great changes. The exposure of illegal production cases in Hebei has reduced the unfavorable factors that disrupted market competition. Recently, factories have stopped production and restricted production. It is expected that the market competition pattern will change in the later period, and prices will stabilize at 26 this month. Ten thousand CNY/ton.

Affected by the locust disaster, malathion's original medicine increased its export orders, and the market quotation was still at a high of 29,000 CNY/ton. Tensions, this month's quotation stabilized at 41,000 CNY/ton; the phoxim original medicine has passed the medication period and is currently reported at 31,500 CNY/ton.

Fipronil manufacturers are mainly export-oriented, and the current price is reported at 670,000 CNY/ton; with the increase in demand, the current supply of fluazinam has been tight, reported at 500,000 CNY/ton; 450,000 CNY/ton; the stock of chlorfenuron original medicine is still small, but the price of terminal preparations is fiercely competitive, and the price of original medicines soars and falls, reported to 350,000 CNY/ton; CNY/tonne.

The operating rate of Pyridoxaline is improved, and the supply is stable. The quotation is 113,000 CNY/ton; the market price of spiroxamate is reported to be 140,000 CNY/ton, which is relatively stable; the recent operation rate of acetylpyridin has recovered, the market price is 3.85 10,000 CNY/ton; the demand for indoxacarb is increasing, the inventory is decreasing, and the market price is stable at 1.07 million CNY/ton.

Fungicide market

The operating rate of the difenoconazole original drug has increased, and the market price has dropped to 230,000 CNY/ton; the price of propiconazole original drug has been maintained at a low level for a long time, and the current price is reported to 96,000 CNY/ton; the original drug of tebuconazole is India The supply of goods gradually entered, and the market price stabilized at 160,000 CNY/ton; the operating rate of tebuconazole original drug manufacturers increased, but the market confidence was insufficient, and the price was mainly reduced to 135,000 CNY/ton; the tricyclazole original drug manufacturers started The rate has also improved, and the market price has dropped to 72,000 CNY/ton; the supply of fluconazole in the original drug market is still tight, and the price of circulating supply is reported to 750,000 CNY/ton; there are fewer manufacturers in the original market of fluosilazole, at 400,000 yuan /Ton.

The operating rate of pyraclostrobin technical manufacturers has increased, and the supply has increased. Each manufacturer is facing competitive pressure, and the price is reported to 178,000 CNY/ton; the raw materials of azoxystrobin technical raw materials have risen sharply, and the manufacturers have cautiously quoted orders and the market has reported 262,000 yuan. Per ton; most of the production of protozoate is stopped, the stock is low, and the market price is reported to be 330,000 CNY/ton; the domestic manufacturer of oxytetracycline is not started, the inventory is low, and the market price remains at a high level of 580,000 CNY/ton , The supply is tight.

Manufacturers of carbendazim and thiophanate methyl have great pressure on environmental protection, the operating rate is average, and the market price is 36,000 CNY/ton; the market price of oxamicarb is reported to 120,000 CNY/ton, and the demand is weak. ; The concentration of fluazinam raw material manufacturers is concentrated, and the market has a hesitant sentiment. The current price has fallen to 300,000 CNY/ton; the operating rate of prochloraz has increased, but the market demand has entered a low season, and the price has fallen sharply, reported to 95,000 yuan /Ton.

The production rate of cyanoxazole is insufficient, the market supply is tight, the quotation is raised to 870,000 CNY/ton, the market spot is very few; the manufacturers of thiofuramide original medicine are concentrated, and the market reports 320,000 CNY/ton; the original enoylmorpholine The operating rate of medicines has rebounded, but the inventory is still at a low level, and the market price is 160,000 CNY/ton; the supply of the original medicine of acetocarb and isoprofen is still tight, and the prices are reported to 150,000 CNY/ton, 182,000 CNY/ton, The small product market is still superior to the bulk of original drug products.

Intermediate market: This month, crude oil prices continued to fluctuate and consolidate, and basic chemical raw materials have no cost and demand support. This month, CCMP reached a position of 85,000 CNY/ton; the market price of CCMT remained at 60,000 CNY/ton, which was relatively stable; the price of pyrethroid intermediate methyl bentonate was reported at 80,000 CNY/ton. 170,000 CNY/ton, ether aldehyde is affected by the supply of India, the price surged back to 90,000 CNY/ton, there are still large variables in the later period. The low-cost state of basic raw materials will gradually reduce the cost of the fine chemical industry over time, and the cost support will become weaker.